Skip to content

Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair

Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair: a Prospective Randomized Controlled Trial.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06737068
Enrollment
120
Registered
2024-12-17
Start date
2025-01-01
Completion date
2027-01-31
Last updated
2024-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Hiatal, Pneumoperitoneum, Postoperative Pain, Shoulder Pain

Brief summary

The goal of this clinical trial is to evaluate the incidence and severity of post-operative shoulder pain following elective robot-assisted hiatal hernia repair in hopes of reducing pain and associated costs as well as clinic and emergency department visits due to this pain. You will undergo standard robot-assisted hiatal hernia repair with the standard postoperative care. The only difference is that you may be selected for the group where lower pressures used to fill your abdomen with carbon dioxide will be used, and you will be asked to fill out logs regarding your pain postoperatively. You will have postoperative appointments that are standard following this procedure.

Interventions

PROCEDURELow pressure pneumoperitoneum (8-10mmHg) with AirSeal device

Elective robot assisted hiatal hernia repair with low pressure pneumoperitoneum (8-10mmHg) with AirSeal device

PROCEDUREStandard pressure pneumoperitoneum (13- 15 mmHg) with AirSeal device

Elective robot assisted hiatal hernia repair with standard pressure pneumoperitoneum (13- 15 mmHg) with AirSeal device

Sponsors

Riverside University Health System Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients undergoing elective robot assisted hiatal hernia repair

Exclusion criteria

* patients less than 18 years of age * conversion to open surgery * BMI \> 40 * history of abdominoplasty * history of chronic pain and/or opioid dependence * history of COPD and/or supplemental oxygen use * pregnant patients * incarcerated patients * patient refusal

Design outcomes

Primary

MeasureTime frameDescription
Reduction in post-operative shoulder pain1 week (on average)Percentage reduction in post-operative shoulder pain from POD#0 to \ 1 week post-operative telephone appointment

Secondary

MeasureTime frameDescription
Severity of postoperative shoulder pain on POD #118 hours (on average)Severity of postoperative shoulder pain on POD #1 (when surgical team rounds \ 6-8AM)
Severity of postoperative shoulder pain at ~1 week1 week (on average)Severity of postoperative shoulder pain at \ 1 week post-operative telephone appointment
Severity of postoperative shoulder pain at ~2 weeks post-op2 weeks (on average)Severity of postoperative shoulder pain at \ 2 week postoperative clinic visit measured by numeric pain rating scale and morphine milligram equivalents
length of hospital staythrough study completion, an average of 2 yearslength of hospital stay
Severity of postoperative shoulder pain on POD #06 hours (on average)Severity of postoperative shoulder pain on POD #0 (recorded at nursing shift change \ 7PM)
number of postoperative clinic visits related to shoulder pain managementthrough study completion, an average of 2 yearsnumber of postoperative clinic visits related to shoulder pain management
discharge dispositionthrough study completion, an average of 2 yearsdischarge disposition (home, SNF, rehab, etc)
standard vs extended narcotic regimenthrough study completion, an average of 2 yearsstandard vs extended (requiring refill) narcotic regimen
quality of life1 week (on average)quality of life assessed via EQ-5D-5L and EQ-VAS questionnaires
readmission rates for shoulder painthrough study completion, an average of 2 yearsreadmission rates for chief complaint of shoulder pain

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026